NRH ACO LLC
901 N. Porter Ave.
Norman, OK. 73071
LeAnn Richardson
Executive Director
405-307-3037
lrichardson@nrh-ok.com
Blanchard Family Medicine, ACO Participant in Joint Venture (No)
Newcastle Family Medicine Center, ACO Participant in Joint Venture (No)
Waterview Medical Centre, ACO Participant in Joint Venture (No)
Waterview Medical Centre, ACO Participant in Joint Venture (No)
NRHS West Family Medicine Associates, ACO Participant in Joint Venture (No)
NRHS Internal Medicine Associates, ACO Participant in Joint Venture (No)
NORMAN REGIONAL PROVIDERS-PRIMARY CARE, ACO Participant in Joint Venture (No)
Findley Family Medicine, ACO Participant in Joint Venture (No)
Ryan Turner, M.D.
Chariman
Voting Power: 1
Participant Representative
Norman Regional Providers - Primary Care
Elise Weisner, M.D.
Voting Member
Voting Power: 1
Participant Representative
Norman Regional Providers - Primary Care
Kevin O’Brien, M.D.
Voting Member
Voting Power: 1
Participant Representative
Norman Regional Providers - Primary Care
Todd Swearingen, D.O.
Voting Member
Voting Power: 1
Participant Representative
Norman Regional Providers - Primary Care
Casey Peters, M.D.
Voting Member
Voting Power: 1
Participant Representative
Norman Regional Providers - Primary Care
Patrick Livingston, D.O.
Voting Member
Voting Power: 1
Participant Representative
Norman Regional Providers - Primary Care
Don Hull, PhD
Voting Member
Voting Power: 1
Medicare Beneficiary
Meegan Carter
Voting Member
Voting Power: 1
Health System Representative
Steven Dodge
ACO Executive Director
Voting Power: 0
Richie Splitt
Voting Power: 0
Health System Representative
ACO Executive - Meegan Carter
Medical Director - Kevin O'Brien, M.D.
Compliance Officer - Courtney Blau
Quality Assurance/Improvement Officer - Rachel Minatee
Finance: Patrick Livingston, D.O., Chair
Clinical Transformation: Elise Weisner M.D., Chair
Quality Assurance: Kevin O'Brien, M.D., Chair
Compliance: Todd Swearingen, D.O., Chair
ACO professionals in a group practice arrangement. Networks of individual practices of ACO professionals.
Amount of Shared Savings/Losses
First Agreement Period
Performance Year 2018, $0
Performance Year 2017, $0
First Agreement Period
Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Performance Year 2017
- Proportioin invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
2017 Quality Performance Results: |
|||
ACO# | Measure Name | Rate | ACO Mean |
ACO-1 | CAHPS: Getting Timely Care, Appointments, and Information | 88.16 | 86.14 |
ACO-2 | CAHPS: How Well Your Providers Communicate | 94.72 | 93.93 |
ACO-3 | CAHPS: Patients' Rating of Provider | 93.32 | 92.45 |
ACO-4 | CAHPS: Access to Specialists | 82.78 | 81.50 |
ACO-5 | CAHPS: Health Promotion and Education | 56.56 | 59.26 |
ACO-6 | CAHPS: Shared Decision Making | 63.38 | 61.94 |
ACO-7 | CAHPS: Health Status/Functional Status | 71.12 | 73.35 |
ACO-34 | CAHPS: Stewardship of Patient Resources | 25.95 | 26.26 |
ACO-8 | Risk-Standardized, All Condition Readmission | 14.74 | 14.98 |
ACO-35 | Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) | 18.04 | 18.59 |
ACO-37 | All-Cause Unplanned Admissions for Patients with Heart Failure | 73.89 | 76.75 |
ACO-38 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions | 57.07 | 59.00 |
ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | 1.34 | 1.98 |
ACO-11 | Use of Certified EHR Technology | 100.00 | 98.20 |
ACO-12 | Medication Reconciliation Post-Discharge | 100.00 | 85.91 |
ACO-13 | Falls: Screening for Future Fall Risk | 60.92 | 79.73 |
ACO-44 | Use of Imaging Studies for Low Back Pain | 50.00 | 64.36 |
ACO-14 | Preventive Care and Screening: Influenza Immunization | 55.88 | 72.71 |
ACO-15 | Pneumonia Vaccination Status for Older Adults | 78.34 | 75.97 |
ACO-16 | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up | 53.51 | 76.83 |
ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 40.74 | 72.81 |
ACO-18 | Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan | 61.87 | 66.74 |
ACO-19 | Colorectal Cancer Screening | 70.25 | 68.27 |
ACO-20 | Breast Cancer Screening | 74.09 | 71.96 |
ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 79.46 | 81.47 |
ACO-27 | Diabetes Mellitus: Hemoglobin A1c Poor Control | 15.91 | 15.51 |
ACO-41 | Diabetes: Eye Exam | 56.06 | 52.42 |
ACO-28 | Hypertension (HTN): Controlling High Blood Pressure | 76.45 | 73.10 |
ACO-30 | Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic | 85.85 | 88.92 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.
- For 2018 Quality Performance Results please visit: HERE
- For 2017 Quality Performance Results please visit: HERE
Note: In the Quality Performance Results file(s) above, search for “NRH ACO LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A3233 in the public use files on data.cms.gov.
No, our ACO does not use the SNF 3-Day Rule Waiver.